Groninger Formularium APP
Information update March 10, 2022
The Groninger Formulary aims to promote the rational use of medicines.
The formulary supports the prescriber in the pharmacotherapeutic treatment by indicating the location of the preferred agents for each indication with a therapeutic consideration. In this way it is indicated more clearly than with a ranking when the different agents are suitable for the different stages of the disease and/or different co-morbidities. In order to achieve better coordination of the pharmacotherapy policy of doctors and pharmacists, a monograph has been included for each medicine with relevant information about the use of the medicine, the side effects, the contraindications, use during pregnancy and lactation and the precautions that must be taken. New in this edition is the indication of the children's doses under the letter K. Due to this separate coding, a children's dose can be found efficiently. The source of the children's doses is the Kinderformularium (www.kinderformularium.nl).
An important way to achieve the above goals is to have the formulary function as a guideline for pharmacotherapy consultations (FTO) between doctors and pharmacists. Finally, the formulary aims to better coordinate prescribing between primary and secondary care. Where necessary, the input of medical specialists as referees and the current transmural guidelines were used for this purpose.
Method
The update of the formulary is based on recent developments in pharmacotherapy. The decisions about choices are mainly based on authoritative Dutch consensus texts, such as the NHG standards, multidisciplinary guidelines, specialist guidelines and the Pharmacotherapeutic Compass. Changes in and additions to these standards must be substantiated by relevant literature.
Decision
Decision-making is based on the Decision Support Model (BOM). For this edition, the committee has worked with a renewed BOM which can be consulted via the website of the Groninger Pharmacy Association (www.gavgroningen.nl). In principle, the medicinal product must be registered for the relevant indication. Only substances that have been registered in the Netherlands for more than three years are included, unless there is ample experience with the use of the substance. The following criteria play a role when comparing resources:
- effectiveness; where possible on the basis of research on hard endpoints.
- safety; the potential for serious side effects and relevant interactions.
- tolerance; the extent to which the common side effects are tolerated.
- applicability; limitation of applicability due to contraindications, age, etc.
- ease of use; manageability in everyday life.
- experience in the region.
When the resources are equivalent on the basis of these criteria, the cost is the deciding factor.
accountability
The Groninger Formulary Committee of the Groninger Pharmacy Association has worked as carefully as possible in compiling the formulary. Nevertheless, the Groninger Formulary Committee and the Groninger Pharmacy Association cannot accept any liability for the consequences that could arise from any inaccuracy in the text. Responsibility for the correctness and completeness of the prescription to the patient remains with the prescriber.
Groninger Formulary Committee
February 2016
Read more
The Groninger Formulary aims to promote the rational use of medicines.
The formulary supports the prescriber in the pharmacotherapeutic treatment by indicating the location of the preferred agents for each indication with a therapeutic consideration. In this way it is indicated more clearly than with a ranking when the different agents are suitable for the different stages of the disease and/or different co-morbidities. In order to achieve better coordination of the pharmacotherapy policy of doctors and pharmacists, a monograph has been included for each medicine with relevant information about the use of the medicine, the side effects, the contraindications, use during pregnancy and lactation and the precautions that must be taken. New in this edition is the indication of the children's doses under the letter K. Due to this separate coding, a children's dose can be found efficiently. The source of the children's doses is the Kinderformularium (www.kinderformularium.nl).
An important way to achieve the above goals is to have the formulary function as a guideline for pharmacotherapy consultations (FTO) between doctors and pharmacists. Finally, the formulary aims to better coordinate prescribing between primary and secondary care. Where necessary, the input of medical specialists as referees and the current transmural guidelines were used for this purpose.
Method
The update of the formulary is based on recent developments in pharmacotherapy. The decisions about choices are mainly based on authoritative Dutch consensus texts, such as the NHG standards, multidisciplinary guidelines, specialist guidelines and the Pharmacotherapeutic Compass. Changes in and additions to these standards must be substantiated by relevant literature.
Decision
Decision-making is based on the Decision Support Model (BOM). For this edition, the committee has worked with a renewed BOM which can be consulted via the website of the Groninger Pharmacy Association (www.gavgroningen.nl). In principle, the medicinal product must be registered for the relevant indication. Only substances that have been registered in the Netherlands for more than three years are included, unless there is ample experience with the use of the substance. The following criteria play a role when comparing resources:
- effectiveness; where possible on the basis of research on hard endpoints.
- safety; the potential for serious side effects and relevant interactions.
- tolerance; the extent to which the common side effects are tolerated.
- applicability; limitation of applicability due to contraindications, age, etc.
- ease of use; manageability in everyday life.
- experience in the region.
When the resources are equivalent on the basis of these criteria, the cost is the deciding factor.
accountability
The Groninger Formulary Committee of the Groninger Pharmacy Association has worked as carefully as possible in compiling the formulary. Nevertheless, the Groninger Formulary Committee and the Groninger Pharmacy Association cannot accept any liability for the consequences that could arise from any inaccuracy in the text. Responsibility for the correctness and completeness of the prescription to the patient remains with the prescriber.
Groninger Formulary Committee
February 2016
voice ai 
g camera 
oled saver 
lite 
chplay 
lionapk 
imo lite 
esound 
ထိုင်း မြန်မာဘာသာပြန် 
google opinion rewards 
oppo 
кинопоиск 
webview 
telebox 
နှစ်တစ်ရာ ပြက္ခဒိန် 
zapya 
soy rappi 
bandlab 
termux 
蝦皮 
